Subconjunctival Palomid 529 in the treatment of neovascular age-related macular degeneration

BACKGROUND: Recent evidence suggests that neovascular age-related macular degeneration (AMD) may have an immune mediated component. Palomid 529, an investigational medication involving the immune Akt/mTOR pathway, is unique in dissociating both targets of rapamycin complexes TORC1 and TORC2. This sm...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dalal, Monica, Jacobs-El, Naima, Nicholson, Benjamin, Tuo, Jingsheng, Chew, Emily, Chan, Chi-Chao, Nussenblatt, Robert, Ferris, Frederick, Meyerle, Catherine
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4153380/
https://ncbi.nlm.nih.gov/pubmed/23689994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00417-013-2375-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky